REG - Boston International - Subscription Agreement signed, GM Notice, New CLNs

Boston International HoldingsAnnouncement

29/10/2024 11:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241029:nRSc0728Ka&default-theme=true

RNS Number : 0728K  Boston International Holdings PLC  29 October 2024

The information contained within this announcement is deemed by the Company to
constitute inside information for the purposes of Article 7 of EU Regulation
596/2014 (which forms part of domestic UK law pursuant to the European Union
(Withdrawal) Act 2018) ("UK MAR"). Upon the publication of this announcement
via a Regulatory Information Service, this information is considered to be in
the public domain.

For immediate release

29 October 2024

BOSTON INTERNATIONAL HOLDINGS PLC

("BIH" or the "Company")

Execution of Subscription Agreement for a 51% Shareholding in the Company

Publication and Despatch of Circular

Notice of General Meeting

New Convertible Loan Notes

On 18 July 2024, the Company announced that it had countersigned the letter of
intent dated 30 June 2024 (the "LOI") received from Linkvalue Investment
Limited ("LVIL") in relation to the proposed subscription by LVIL (or its
nominee) for 222,407,081 new ordinary shares of 0.1 pence each in the Company
for £306,000 in cash, payable on completion of such subscription (the
"Subscription").  The Company is pleased to announce that earlier today,
Zarara Energy Ltd ("ZEL"), the nominee of LVIL for the purpose, and LVIL (as
guarantor) entered into a subscription agreement with the Company in respect
of the Subscription, completion of which is subject to, inter alia, certain
approvals of the shareholders of the Company. Such number of new ordinary
shares would represent 60.00% of the enlarged issued share capital of the
Company and 51.00% of the enlarged fully diluted issued share capital of the
Company assuming conversion of all existing convertible loan notes issued by
the Company and the new convertible loan notes to be issued by the Company on
or immediately prior to completion of the Subscription (as referred to below)
and assuming no other issues of shares by the Company.

ZEL, a newly-incorporated company in Mauritius (and nominated by LVIL for the
purposes of the Subscription), and LVIL have a common shareholder, Alawi
Shukri Saleh Alawi Albreiki, who owns 60% of the share capital of ZEL and 20%
of the share capital of LVIL. His family own the remaining share capital of
LVIL and also own Al Braik Investments LLC, a diversified holding company
based in the United Arab Emirates and specialising in real estate, oil &
gas, hospitality, franchising, investment, construction and construction
support services.

Circular to Shareholders and Notice of General Meeting

In accordance with the terms of the Subscription Agreement, completion of the
Subscription is conditional on approval by shareholders of the Company
("Shareholders") of the requisite resolutions at a general meeting of the
Company (including approval of a waiver resolution for the purposes of Rule 9
of the City Code on Takeovers and Mergers (the "Takeover Code") in relation to
the resultant ZEL shareholding position in the Company (the "Rule 9 Waiver
Resolution")).

Accordingly, a circular will be published later today by the Company (the
"Circular") and will be despatched to Shareholders later today which includes
notice of a general meeting of the Company convened to be held at 11.00 am on
Thursday 14 November 2024 (the "General Meeting") at the offices of Gowling
WLG (UK) LLP, 4 More London Riverside, London SE1 2AU at which the requisite
resolutions will be proposed for the approval of Shareholders.

One of the purposes of the Circular is to provide Shareholders with an
explanation of the Rule 9 Waiver Resolution and to give Shareholders the
information required under the Takeover Code.

A copy of the Circular will be available on the Company's website at
https://www.bihplc.com (https://www.bihplc.com) .  In accordance with UK
Listing Rules of the UK Financial Conduct Authority ("FCA"), a copy of the
Circular will be submitted to the FCA via the National Storage Mechanism and
will shortly be available for viewing at the National Storage Mechanism:
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

Rule 9 Waiver

The Company has applied to the Panel on Takeovers and Mergers (the "Takeover
Panel") for the waiver of the obligation of ZEL to make a general offer for
the Company under Rule 9 of the Takeover Code which would otherwise arise as a
consequence of the allotment and issue of the 222,407,081 new ordinary shares
in the Company to ZEL (the "Rule 9 Waiver") and the Takeover Panel has agreed
to such a Rule 9 Waiver subject to the approval of independent Shareholders of
the Rule 9 Waiver taken on a poll at the General Meeting. Accordingly, the
Rule 9 Waiver being proposed at the General Meeting will be taken by means of
a poll of independent Shareholders attending and voting at the General
Meeting.

The Rule 9 Waiver to which the Takeover Panel has agreed under the Takeover
Code will be invalidated if any purchases are made by ZEL, or any person
acting in concert with it, in the period between the date of this announcement
and the General Meeting.  Neither ZEL, nor any of the directors of ZEL nor
any person acting in concert with ZEL, holds any ordinary shares in the
Company or has purchased any ordinary shares in the Company in the 12 months
preceding the date of this announcement.

Subscription Shares

The 222,407,081 new ordinary shares in the Company to be issued to ZEL at the
subscription price of 0.1376 pence per share (the "Subscription Shares") will
be allotted and issued to ZEL credited as fully paid up and ranking pari
passu, and as one class with, the existing 148,219,943 ordinary shares in the
Company (the "Existing Ordinary Shares").

Under the terms of the Subscription Agreement, ZEL has undertaken that during
the period of 12 months following completion of the Subscription, it will not
sell, transfer of otherwise dispose of, or create any encumbrance over, any of
the Subscription Shares (or any interest in the Subscription Shares), or enter
into any agreement to do so, subject to certain limited exceptions.

ZEL has also given undertakings to the Company in the Subscription Agreement,
for so long as ZEL holds a majority of the voting rights in the Company, as
to:-

-      exercising its voting rights to, inter alia, procure that the
Company and the Company's business are managed for the benefit of the
Shareholders as a whole and independently of ZEL, that all transactions,
agreements, relationships and arrangements between the Company and ZEL shall
be on an arm's length basis and on normal commercial terms and that the quorum
for any meeting of the board of directors of the Company (the "Board") (or any
committee of the Board) shall include a Director who is not one of the
Proposed Directors (as referred to below) or an appointee or nominee of ZEL
(an "Independent Director") (or, if the meeting is adjourned because of no
quorum, those Directors who attend); and

-      not influencing or seeking to influence the running of the Company
at an operational level; exercising the voting rights attaching to the
Subscription Shares and any other ordinary shares in the Company in which ZEL
is interested from time to time in respect of (i) any resolution relating to a
transaction, agreement or arrangement with or relating to ZEL or (ii) any
resolution to cancel the admission of the Company's shares to listing on the
FCA's Official List or to trading on the LSE's Main Market other than with the
consent of the Independent Directors or in connection with an offer for the
entire issued share capital of the Company made by a person other than ZEL or
any person(s) acting in concert with ZEL or (iii) to procure or seek to
procure any amendment to the Articles which would be inconsistent with such
undertakings.

The listing of the Existing Ordinary Shares on the Official List ('standard'
segment) and dealings in the Existing Ordinary Shares was suspended at 5.00
p.m. on 27 April 2023 and remains suspended at the date of this announcement.
Whilst the listing of the Existing Ordinary Shares on the Official List was
transferred from the 'standard' segment to the 'Equity shares (shell
companies)' segment on 29 July 2024 (when the new UK Listing Rules became
effective), such suspension is continuing and it is not anticipated that the
suspension will be lifted by the date of completion of the Subscription. No
application has been made, or will therefore be made for the time being, for
the Subscription Shares to be admitted to listing on the Official List or to
trading on the London Stock Exchange's main market for listed securities.

Board changes

On completion of the Subscription, two nominee Directors of ZEL - Said Mbarak
Salim Al Digeil (aged 76) and William ('Brock') Henry Tuppeny III (aged 63)
(the "Proposed Directors") - will be appointed to the Board as nominees for
ZEL and Martin Lampshire and Richard Hartheimer will resign from the Board
(without payment of any compensation). Further information regarding the
Proposed Directors is set out in the Circular.

There are no disclosures to be made under UK Listing Rule 6.4.8R in respect of
either of the Proposed Directors and neither of the Proposed Directors owns
any shares in the Company.

Use of subscription monies

The Company intends to use the subscription monies received for the
Subscription Shares (net of expenses) to pay agreed unpaid creditors of the
Company (including professional advisers), and also accounting costs in
relation to the preparation and audit of the financial statements of the
Company for the financial year ended 31 December 2023 (announced on 17 October
2024).

Deposit

Pursuant to the LOI (and as announced by the Company on 18 July 2024), LVIL
paid a cash deposit of £65,000 (the "Deposit") to the Company on 16 July
2024, to be used by the Company to pay certain agreed creditors and
professional fees. If the approval of Shareholders and other regulatory
approvals required to complete the Subscription are not received (and a
substantively similar transaction is not entered into and completed between
the parties), the Company is obliged to take all necessary action to procure
that the Deposit is converted into 22,960,247 new ordinary shares in the
Company, being such number of ordinary shares as would represent 10.833% of
the Company's share capital on a fully diluted basis.

Conversion of Outstanding Directors' Fees and Expenses into New Convertible
Loan Notes

The Company also announces that on or immediately prior to (and as a condition
of) completion of the Subscription, the following persons/parties have agreed
to convert the following outstanding fees and expenses due from the Company to
them and their consultancy companies into an aggregate principal amount of
£246,982.20 new convertible loan notes (the "New Convertible Loan Notes") to
be created and issued by the Company pursuant to a new convertible loan note
instrument to be executed by the Company (the "New Convertible Loan Note
Instrument"):-

 Person/Party                     Nature of Amounts due               Amount due    Principal Amount of New Convertible Loan Notes
 Christopher Pitman               Director's fees (to 30 April 2024)  £58,999.92    £58,999.92
 05 Management Limited*           Expenses                            £33,815.86    £33,815.86
 Experience Capital Limited(†)    Director's fees (to 30 April 2024)  £49,999.92    £49,999.92
 Borden James                     Director's fees (to 30 April 2024)  £52,083.25    £52,083.25
 Richard Hartheimer               Director's fees (to 30 April 2024)  £52,083.25    £52,083.25
 Total                                                                £246,982.20   £246,982.20

(*       a consultancy company owned and controlled by Christopher
Pitman)

((†)       a consultancy company owned and controlled by Martin
Lampshire)

Each of the Directors has agreed and confirmed in writing to ZEL and LVIL and
to the Company that no further Director's fees are or will be payable to them
(or their consultancy companies) for the period since 30 April 2024.

The terms of the New Convertible Loan Notes, as follows:-

(i)       the New Convertible Loan Notes will have a 'final repayment
date' of 31 December 2025 (the "Final Repayment Date"); and

(ii)      the New Convertible Loan Notes will be convertible into
ordinary shares in the Company at a conversion price of 1 pence per ordinary
share:-

-         at any time by the holders (the "Noteholders") with the
written consent of the Company (such consent to be given or withheld by the
Company in its absolute discretion), at any time prior to the Final Repayment
Date (provided that the Company shall not give consent to any such conversion
if the obligation on the Company to submit an application for the ordinary
shares in the Company resulting from such conversion to be admitted to listing
on the Official List ("Listing") and to trading on the London Stock Exchange's
main market for listed securities (the "LSE's Main Market")) or to trading on
a recognised stock exchange in accordance with the New Convertible Loan Note
Instrument would of itself, require the Company to prepare and publish a
Prospectus in connection with the applications to admit the ordinary shares in
the Company resulting from such conversion); and

-         automatically on the earlier of (i) the publication by the
Company of a prospectus which covers the admission of the ordinary shares in
the Company arising on conversion of the New Convertible Loan Notes to Listing
and to trading on the LSE's Main Market; and completion by the Company of an
'RTO' (as defined in the New Convertible Loan Note Instrument) involving the
issue of ordinary shares in the Company as consideration at an effective issue
price of 1 pence or more per ordinary share and/or a simultaneous equity
fundraising by the Company at an issue price of 1 pence or more per ordinary
share and the admission of the whole of the issued and to be issued share
capital of the Company either to Listing and to trading on the LSE's Main
Market or to trading on a recognised stock exchange.

Related party transactions

The issues of the aggregate £246,982.20 principal of New Convertible Loan
Notes to the Directors (and any associates of theirs) as set out above
constitute 'material related party transactions' for the purposes of DTR
7.3.8R.  Considering the Company's need to conserve cash and to put its
Convertible Loan Note arrangements on a solvent basis and the requirements of
ZEL in relation to the Subscription, the Board considers that the terms of
such 'related party transactions' are fair and reasonable insofar as the
Shareholders as a whole are concerned and accordingly has approved them. In
the Board's consideration, each transaction with individual Directors (and any
associates) has been separately considered and in so doing, each Director who
is, or an associate of whom is, the 'related party', has not taken part in the
Board's consideration of each transaction and has not voted on the relevant
Board resolution.

Recommendation

The Directors, who have been so advised by Beaumont Cornish Limited ("Beaumont
Cornish"), consider that the Subscription is fair and reasonable insofar as
the Shareholders are concerned and in the best interests of the Company and
its Shareholders as a whole.  In providing its advice to the Directors,
Beaumont Cornish has taken into account the commercial assessments of the
Directors.

Accordingly, the Directors are unanimously recommending that Shareholders vote
in favour of all the resolutions (including the Rule 9 Waiver Resolution) to
be proposed at the General Meeting, as they intend to do in respect of their
own beneficial shareholdings (and shareholdings over which they have control)
amounting to in aggregate 40,000,100 ordinary shares in the Company
(representing approximately 26.99 per cent. of the Company's issued share
capital at the date of this announcement).

The Subscription is conditional, inter alia, upon the passing of all the
resolutions at the General Meeting.  Shareholders should be aware that if any
of the resolutions is/are not approved at the General Meeting, the
Subscription will not be able to proceed in any respect.  Shareholders are
therefore urged to vote in favour of all the Resolutions.

Christopher Pitman, Chairman of Boston International Holdings Plc, commented:

"The Board is pleased to be able to announce the conclusion of the
negotiations for the Subscription by Zarara Energy Ltd for a majority equity
stake in the Company and the convening of the General Meeting to approve the
Subscription, which if completed, will enable the Company to pursue potential
acquisition opportunities in the oil & gas sector."

"

For more information, please contact:-

 Boston International Holdings Plc
 Christopher Pitman, Chairman                         +44 (0) 7768 104329
 Beaumont Cornish Limited (Rule 3/Financial adviser)
 Roland Cornish / Asia Szusciak                       +44 (0) 20 7628 3396

Important Notice:-

Beaumont Cornish Limited, which is authorised and regulated in the United
Kingdom by the Financial Conduct Authority, is financial adviser to the
Company in relation to the matters referred herein and the independent adviser
to the Directors of the Company for the purposes of Rule 3 of the Takeover
Code. Beaumont Cornish Limited is acting exclusively for the Company and for
no one else in relation to the matters described in this announcement and is
not advising any other person and accordingly will not be responsible to
anyone other than the Company for providing the protections afforded to
clients of Beaumont Cornish Limited, or for providing advice in relation to
the contents of this announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AGRMLBBTMTJTBAI